Oral iron chelation is here: Author's reply
1991; BMJ; Volume: 303; Issue: 6816 Linguagem: Inglês
10.1136/bmj.303.6816.1546
ISSN0959-8138
Autores Tópico(s)Hemoglobinopathies and Related Disorders
ResumoLI may outweigh the risks of its possible toxicity, and its introduction in such patients may now be appropriate" seem overenthusiastic.Certainly it is in stark contrast to an earlier editorial in the Lancet, which questioned the efficacy of LI and drew attention to the unacceptable incidence of side effects, recommending that "this compound should no longer be given to patients."4
Referência(s)